Schizophrenia Research and Treatment最新文献_第6页

Dimensional information-theoretic measurement of facial emotion expressions in schizophrenia. 精神分裂症患者面部情绪表达的维度信息论测量。

IF 2.4

Schizophrenia Research and Treatment Pub Date : 2014-01-01 Epub Date: 2014-02-25 DOI: 10.1155/2014/243907

Jihun Hamm, Amy Pinkham, Ruben C Gur, Ragini Verma, Christian G Kohler

{"title":"Dimensional information-theoretic measurement of facial emotion expressions in schizophrenia.","authors":"Jihun Hamm, Amy Pinkham, Ruben C Gur, Ragini Verma, Christian G Kohler","doi":"10.1155/2014/243907","DOIUrl":"https://doi.org/10.1155/2014/243907","url":null,"abstract":"Altered facial expressions of emotions are characteristic impairments in schizophrenia. Ratings of affect have traditionally been limited to clinical rating scales and facial muscle movement analysis, which require extensive training and have limitations based on methodology and ecological validity. To improve reliable assessment of dynamic facial expression changes, we have developed automated measurements of facial emotion expressions based on information-theoretic measures of expressivity of ambiguity and distinctiveness of facial expressions. These measures were examined in matched groups of persons with schizophrenia (n = 28) and healthy controls (n = 26) who underwent video acquisition to assess expressivity of basic emotions (happiness, sadness, anger, fear, and disgust) in evoked conditions. Persons with schizophrenia scored higher on ambiguity, the measure of conditional entropy within the expression of a single emotion, and they scored lower on distinctiveness, the measure of mutual information across expressions of different emotions. The automated measures compared favorably with observer-based ratings. This method can be applied for delineating dynamic emotional expressivity in healthy and clinical populations. ","PeriodicalId":45388,"journal":{"name":"Schizophrenia Research and Treatment","volume":"2014 ","pages":"243907"},"PeriodicalIF":2.4,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2014/243907","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32255728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 18

A Comparative Study between Olanzapine and Risperidone in the Management of Schizophrenia. 奥氮平与利培酮治疗精神分裂症的比较研究。

IF 2.4

Schizophrenia Research and Treatment Pub Date : 2014-01-01 Epub Date: 2014-08-26 DOI: 10.1155/2014/307202

Saeed Shoja Shafti, Mahsa Gilanipoor

{"title":"A Comparative Study between Olanzapine and Risperidone in the Management of Schizophrenia.","authors":"Saeed Shoja Shafti, Mahsa Gilanipoor","doi":"10.1155/2014/307202","DOIUrl":"https://doi.org/10.1155/2014/307202","url":null,"abstract":"Introduction. Since a variety of comparisons between risperidone and olanzapine have resulted in diverse outcomes, so safety and efficacy of them were compared again in a new trial. Method. Sixty female schizophrenic patients entered into one of the assigned groups for random allocation to olanzapine or risperidone (n = 30 in each group) in a double-blind, 12-week clinical trial. Scale for Assessment of Positive Symptoms (SAPS) and Scale for Assessment of Negative Symptoms (SANS) were used as the primary outcome measures. Clinical Global Impressions-Severity Scale (CGI-S), Schedule for Assessment of Insight (SAI), and finally Simpson Angus Scale (SAS) as well were employed as secondary scales. Results. While both of olanzapine and risperidone were significantly effective for improvement of positive symptoms (P < 0.0001), as regards negative symptoms, it was so only by means of olanzapine (P < 0.0003). CGI-S and SAI, as well, were significantly improved in both of the groups. SAS increment was significant only in the risperidone group (P < 0.02). Conclusion. While both of olanzapine and risperidone were equally effective for improvement of positive symptoms and insight, olanzapine showed superior efficacy with respect to negative symptoms, along with lesser extrapyramidal side effects, in comparison with risperidone. ","PeriodicalId":45388,"journal":{"name":"Schizophrenia Research and Treatment","volume":"2014 ","pages":"307202"},"PeriodicalIF":2.4,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2014/307202","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32689351","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 14

"Sometimes It's Difficult to Have a Normal Life": Results from a Qualitative Study Exploring Caregiver Burden in Schizophrenia. "有时很难有正常的生活"：探索精神分裂症患者照顾者负担的定性研究结果。

IF 2.4

Schizophrenia Research and Treatment Pub Date : 2014-01-01 Epub Date: 2014-04-03 DOI: 10.1155/2014/368215

Adam Gater, Diana Rofail, Chloe Tolley, Chris Marshall, Linda Abetz-Webb, Steven H Zarit, Carmen Galani Berardo

{"title":"\"Sometimes It's Difficult to Have a Normal Life\": Results from a Qualitative Study Exploring Caregiver Burden in Schizophrenia.","authors":"Adam Gater, Diana Rofail, Chloe Tolley, Chris Marshall, Linda Abetz-Webb, Steven H Zarit, Carmen Galani Berardo","doi":"10.1155/2014/368215","DOIUrl":"10.1155/2014/368215","url":null,"abstract":"Objectives. As a disease typified by early onset and chronic disease course, caring for a person with schizophrenia may have a significant impact on caregivers' lives. This study aimed to investigate the subjective experiences of caregivers of people with schizophrenia as a means of understanding \"caregiver burden\" in this population. Methods. Face-to-face qualitative interviews were conducted with a diverse sample of 19 US-English speaking caregivers of people with schizophrenia (who were at least moderately ill). Interview transcripts were analyzed using grounded theory methods and findings used to inform the development of a preliminary conceptual model outlining caregivers' experiences. Results. Findings support assertions that people with schizophrenia were largely dependent upon caregivers for the provision of care and caregivers subsequently reported lacking time for themselves and their other responsibilities (e.g., family and work). Caregiver burden frequently manifested as detriments in physical (e.g., fatigue, sickness) and emotional well-being (e.g., depression and anxiety). Conclusions. Caring for a person with schizophrenia has a significant impact on the lives of informal (unpaid) caregivers and alleviating caregiver burden is critical for managing individual and societal costs. Future research should concentrate on establishing reliable and valid means of assessing burden among caregivers of persons with schizophrenia to inform the development and evaluation of interventions for reducing this burden. ","PeriodicalId":45388,"journal":{"name":"Schizophrenia Research and Treatment","volume":"2014 ","pages":"368215"},"PeriodicalIF":2.4,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016854/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32370550","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Traditional knowledge and formulations of medicinal plants used by the traditional medical practitioners of bangladesh to treat schizophrenia like psychosis. 孟加拉国传统医师治疗精神分裂症（如精神病）的传统知识和药用植物配方。

IF 2.4

Schizophrenia Research and Treatment Pub Date : 2014-01-01 Epub Date: 2014-06-30 DOI: 10.1155/2014/679810

Md Nasir Ahmed, Md Nur Kabidul Azam

{"title":"Traditional knowledge and formulations of medicinal plants used by the traditional medical practitioners of bangladesh to treat schizophrenia like psychosis.","authors":"Md Nasir Ahmed, Md Nur Kabidul Azam","doi":"10.1155/2014/679810","DOIUrl":"10.1155/2014/679810","url":null,"abstract":"Schizophrenia is a subtle disorder of brain development and plasticity; it affects the most basic human processes of perception, emotion, and judgment. In Bangladesh the traditional medical practitioners of rural and remote areas characterized the schizophrenia as an insanity or a mental problem due to possession by ghosts or evil spirits and they have used various plant species' to treat such symptoms. The aim of the present study was to conduct an ethnomedicinal plant survey and documentation of the formulations of different plant parts used by the traditional medical practitioners of Rangamati district of Bangladesh for the treatment of schizophrenia like psychosis. It was observed that the traditional medical practitioners used a total of 15 plant species to make 14 formulations. The plants were divided into 13 families, used for treatment of schizophrenia and accompanying symptoms like hallucination, depression, oversleeping or insomnia, deterioration of personal hygiene, forgetfulness, and fear due to evil spirits like genies or ghost. A search of the relevant scientific literatures showed that a number of plants used by the medicinal practitioners have been scientifically validated in their uses and traditional medicinal knowledge has been a means towards the discovery of many modern medicines. Moreover, the antipsychotic drug reserpine, isolated from the dried root of Rauvolfia serpentina species, revolutionized the treatment of schizophrenia. So it is very much possible that formulations of the practitioner, when examined scientifically in their entireties, can form discovery of lead compounds which can be used as safe and effective antipsychotic drug to treat schizophrenia. ","PeriodicalId":45388,"journal":{"name":"Schizophrenia Research and Treatment","volume":"2014 ","pages":"679810"},"PeriodicalIF":2.4,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4100298/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32566989","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Residual negative symptoms differentiate cognitive performance in clinically stable patients with schizophrenia and bipolar disorder. 残留阴性症状区分临床稳定的精神分裂症和双相情感障碍患者的认知表现。

IF 2.4

Schizophrenia Research and Treatment Pub Date : 2014-01-01 Epub Date: 2014-06-12 DOI: 10.1155/2014/785310

Rajeev Krishnadas, Seethalakshmi Ramanathan, Eugene Wong, Ajita Nayak, Brian Moore

{"title":"Residual negative symptoms differentiate cognitive performance in clinically stable patients with schizophrenia and bipolar disorder.","authors":"Rajeev Krishnadas, Seethalakshmi Ramanathan, Eugene Wong, Ajita Nayak, Brian Moore","doi":"10.1155/2014/785310","DOIUrl":"https://doi.org/10.1155/2014/785310","url":null,"abstract":"Cognitive deficits in various domains have been shown in patients with bipolar disorder and schizophrenia. The purpose of the present study was to examine if residual psychopathology explained the difference in cognitive function between clinically stable patients with schizophrenia and bipolar disorder. We compared the performance on tests of attention, visual and verbal memory, and executive function of 25 patients with schizophrenia in remission and 25 euthymic bipolar disorder patients with that of 25 healthy controls. Mediation analysis was used to see if residual psychopathology could explain the difference in cognitive function between the patient groups. Both patient groups performed significantly worse than healthy controls on most cognitive tests. Patients with bipolar disorder displayed cognitive deficits that were milder but qualitatively similar to those of patients with schizophrenia. Residual negative symptoms mediated the difference in performance on cognitive tests between the two groups. Neither residual general psychotic symptoms nor greater antipsychotic doses explained this relationship. The shared variance explained by the residual negative and cognitive deficits that the difference between patient groups may be explained by greater frontal cortical neurophysiological deficits in patients with schizophrenia, compared to bipolar disorder. Further longitudinal work may provide insight into pathophysiological mechanisms that underlie these deficits. ","PeriodicalId":45388,"journal":{"name":"Schizophrenia Research and Treatment","volume":"2014 ","pages":"785310"},"PeriodicalIF":2.4,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2014/785310","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32503653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 6

Insight, neurocognition, and schizophrenia: predictive value of the wisconsin card sorting test. 洞察力，神经认知和精神分裂症:威斯康星卡片分类测试的预测价值。

IF 2.4

Schizophrenia Research and Treatment Pub Date : 2013-01-01 Epub Date: 2013-11-04 DOI: 10.1155/2013/696125

John Stratton, Philip T Yanos, Paul Lysaker

引用次数: 8

Sleep, fatigue, and functional health in psychotic patients. 精神病患者的睡眠、疲劳和功能健康

IF 2.4

Schizophrenia Research and Treatment Pub Date : 2013-01-01 Epub Date: 2013-04-30 DOI: 10.1155/2013/425826

Flavie Waters, Neepa Naik, Daniel Rock

{"title":"Sleep, fatigue, and functional health in psychotic patients.","authors":"Flavie Waters, Neepa Naik, Daniel Rock","doi":"10.1155/2013/425826","DOIUrl":"https://doi.org/10.1155/2013/425826","url":null,"abstract":"This study sought to examine the association between sleep, fatigue, and functional health in psychotic patients. Participants included 93 psychotic inpatients (n = 67 with schizophrenia) who completed the Chalder Fatigue Scale (ChFS), the Fatigue Symptom Inventory (FSI), the Pittsburgh Sleep Quality Index (PSQI), and the SF36 Health Survey. Patients were classified on the basis of their performance on sleep and fatigue measures: 60% reported significant levels of fatigue and 67% significant sleep disturbances. 28.4% reported both, suggesting that fatigue and sleep dysfunctions do not necessarily cooccur. A closer examination of patterns showed that fatigue was only related to qualitative aspects of sleep and not quantifiable aspects of sleep disturbances. The results also showed that functional health was the lowest in patients with high levels of fatigue, compared to patients with sleep problems only or patients with neither symptom. A regression analysis further showed that the size of the contribution of fatigue onto functional health was twice as much as that of sleep dysfunctions. In conclusion, the results show that (i) dissatisfaction with sleep-and not sleep itself-is related to fatigue symptoms and that (ii) fatigue is particularly detrimental to functional health, regardless of the presence of sleep dysfunctions.","PeriodicalId":45388,"journal":{"name":"Schizophrenia Research and Treatment","volume":"2013 ","pages":"425826"},"PeriodicalIF":2.4,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/425826","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31482358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 39

The neural correlates of mental rotation abilities in cannabis-abusing patients with schizophrenia: an FMRI study. 精神分裂症大麻滥用患者心理旋转能力的神经相关性:一项FMRI研究。

IF 2.4

Schizophrenia Research and Treatment Pub Date : 2013-01-01 Epub Date: 2013-07-17 DOI: 10.1155/2013/543842

Stéphane Potvin, Josiane Bourque, Myriam Durand, Olivier Lipp, Pierre Lalonde, Emmanuel Stip, Sylvain Grignon, Adrianna Mendrek

{"title":"The neural correlates of mental rotation abilities in cannabis-abusing patients with schizophrenia: an FMRI study.","authors":"Stéphane Potvin, Josiane Bourque, Myriam Durand, Olivier Lipp, Pierre Lalonde, Emmanuel Stip, Sylvain Grignon, Adrianna Mendrek","doi":"10.1155/2013/543842","DOIUrl":"https://doi.org/10.1155/2013/543842","url":null,"abstract":"Growing evidence suggests that cannabis abuse/dependence is paradoxically associated with better cognition in schizophrenia. Accordingly, we performed a functional magnetic resonance imaging (fMRI) study of visuospatial abilities in 14 schizophrenia patients with cannabis abuse (DD), 14 nonabusing schizophrenia patients (SCZ), and 21 healthy controls (HCs). Participants performed a mental rotation task while being scanned. There were no significant differences in the number of mistakes between schizophrenia groups, and both made more mistakes on the mental rotation task than HC. Relative to HC, SCZ had increased activations in the left thalamus, while DD patients had increased activations in the right supramarginal gyrus. In both cases, hyper-activations are likely to reflect compensatory efforts. In addition, SCZ patients had decreased activations in the left superior parietal gyrus compared to both HC and DD patients. This latter result tentatively suggests that the neurophysiologic processes underlying visuospatial abilities are partially preserved in DD, relative to SCZ patients, consistently with the findings showing that cannabis abuse in schizophrenia is associated with better cognitive functioning. Further fMRI studies are required to examine the neural correlates of other cognitive dysfunctions in schizophrenia patients with and without comorbid cannabis use disorder. ","PeriodicalId":45388,"journal":{"name":"Schizophrenia Research and Treatment","volume":"2013 ","pages":"543842"},"PeriodicalIF":2.4,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/543842","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31678755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 14

Correlates of Caregiver Burden among Family Members of Patients with Schizophrenia in Lagos, Nigeria. 尼日利亚拉各斯精神分裂症患者家庭成员照顾者负担的相关因素

IF 2.4

Schizophrenia Research and Treatment Pub Date : 2013-01-01 Epub Date: 2013-10-03 DOI: 10.1155/2013/353809

Increase Ibukun Adeosun

{"title":"Correlates of Caregiver Burden among Family Members of Patients with Schizophrenia in Lagos, Nigeria.","authors":"Increase Ibukun Adeosun","doi":"10.1155/2013/353809","DOIUrl":"https://doi.org/10.1155/2013/353809","url":null,"abstract":"Family members of patients with schizophrenia have enormous roles in the care of their patients, which could negatively impact their well being. Development of interventions targeted at alleviating the burden of informal care giving is hinged on the recognition of the factors associated with the various dimensions of burden. This study determined the correlates of caregiver burden among family members of patients with schizophrenia in Lagos, Nigeria. The study instruments included the Zarit burden interview (ZBI) and the positive and negative syndrome scale for schizophrenia (PANSS). Exploratory factor analysis of the ZBI produced a five-factor structure with \"financial/physical strain\", \"time/dependence strain\", \"emotional strain\", \"uncertainty\", and \"self-criticism\" domains. On multiple regression analyses, total PANSS scores, poor social support, and lower educational levels of caregivers were predictive of higher burden scores on the \"financial/physical strain\", \"time/dependence\", and \"emotional strain\" domains. Longer duration of illness, shorter patient-caregiver contact time, and being a female caregiver were predictive of higher burden scores on the \"uncertainty\", \"self-criticism\", and \"emotional strain\" domains, respectively. There is need for interventions to alleviate the burden on caregivers of patients with schizophrenia in Nigeria. These strategies must include comprehensive social support and improve access to services for patients and their caregivers. ","PeriodicalId":45388,"journal":{"name":"Schizophrenia Research and Treatment","volume":"2013 ","pages":"353809"},"PeriodicalIF":2.4,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/353809","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31858065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 91

Atypical antipsychotics in the treatment of depressive and psychotic symptoms in patients with chronic schizophrenia: a naturalistic study. 非典型抗精神病药物治疗慢性精神分裂症患者的抑郁和精神病症状:一项自然主义研究

IF 2.4

Schizophrenia Research and Treatment Pub Date : 2013-01-01 Epub Date: 2013-01-21 DOI: 10.1155/2013/423205

Marco Innamorati, Stefano Baratta, Cristina Di Vittorio, David Lester, Paolo Girardi, Maurizio Pompili, Mario Amore

{"title":"Atypical antipsychotics in the treatment of depressive and psychotic symptoms in patients with chronic schizophrenia: a naturalistic study.","authors":"Marco Innamorati, Stefano Baratta, Cristina Di Vittorio, David Lester, Paolo Girardi, Maurizio Pompili, Mario Amore","doi":"10.1155/2013/423205","DOIUrl":"https://doi.org/10.1155/2013/423205","url":null,"abstract":"Objectives. The aim of this naturalistic study was to investigate whether treatment with clozapine and other atypical antipsychotics for at least 2 years was associated with a reduction in psychotic and depressive symptoms and an improvement in chronic schizophrenia patients' awareness of their illness. Methods. Twenty-three adult outpatients (15 men and 8 women) treated with clozapine and 23 patients (16 men and 7 women) treated with other atypical antipsychotics were included in the study. Psychotic symptoms were evaluated using the Positive and Negative Syndrome Scale (PANSS), depressive symptoms were assessed with the Calgary Depression Scale for Schizophrenia (CDSS), and insight was assessed with the Scale to Assess Unawareness of Mental Disorder (SUMD). Results. The sample as a whole had a significant reduction in positive, negative, and general symptoms, whereas the reduction in depression was significant only for patients with CDSS scores of 5 and higher at the baseline. At the follow-up, patients treated with other atypical antipsychotics reported a greater reduction in depression than patients treated with clozapine, but not when limiting the analyses to those with clinically relevant depression. Conclusions. Atypical antipsychotics may be effective in reducing psychotic and depressive symptoms and in improving insight in patients with chronic schizophrenia, with no differences in the profiles of efficacy between compounds.","PeriodicalId":45388,"journal":{"name":"Schizophrenia Research and Treatment","volume":"2013 ","pages":"423205"},"PeriodicalIF":2.4,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/423205","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31232420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 8